Patent · US Active

Substituted pyrrolizine compounds and uses thereof

US10836769B2 · kind B2 · utility

4Cited by
5References
53Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2019
Grant dateNov 17, 2020
Priority date
Expiry dateFeb 25, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/20
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This application relates generally to certain substituted pyrrolizine compounds, and pharmaceutical compositions which inhibit HBV replication, and methods of making and using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.